According to VCBeat, "Menxlab Manshi" ("Menxlab"), a platform for men's health management, has raised tens of millions in its Pre-A round, jointly led by SIG China and Gaorong Capital, with participation from other well-known investors. Inspur Capital acts as the exclusive financial adviser for this funding round. It comes less than three months after Menxlab announced its completion of the angel round.

Proceeds from the latest round will be used for independent research and development of products, sale channels upgrading, team building and others. Based on data and products, Menxlab will build a digital life cycle management system for users in the future. At the same time, a new brand of Menxlab's washing and care series has been officially launched this month on TMALL and other e-commerce platforms.

Menxlab is the first new brand of men's health management launched by Shenzhen Manshi Technology Co., Ltd. It mainly aims at the health problems of men aged 20-45 such as hair loss, health care, and skincare, and provides them with medical consumer-grade products and comprehensive solutions.

In the face of the huge population of hair loss with market demand, Menxlab starts from provides a complete solution for people with hair loss. For customers with early and middle hair loss stage, they can choose basic shampoo and scalp care shampoo to reduce hair loss and help hair regeneration.

SIG's China venture capital and private equity activities are operated through SIG China, LLLP (SAI) and its wholly foreign-owned enterprise (WFOE) based in Shanghai with a branch office in Beijing. The SIG China team seeks to commit the firm's capital to venture capital and private equity investments in China.

Gaorong Capital is devoted to creating a better life through innovation. It is dedicated to identifying the leading founders and collaborating with them to achieve long-term value. Gaorong Capital focuses on the investment of innovations in technology and business models along with industrial integration.